Thus, DKK-1 seems to have a dual action in colon cancer, that is analogous to that of transforming growth factor (TGF)-β [39, 40], a suppressive action at early stages, by inhibiting cell proliferation by both Wnt-dependent and -independent mechanisms, and a tumor promoting action at later stages of progression, by inducing chemoresistance. The gene discussed is TGFB1; the disease is malignant colon neoplasm.